EXPM:ISOLF - Post by User
Post by HiMyNameIson Mar 05, 2021 9:08am
226 Views
Post# 32726442
ISOL reports on CSE
ISOL reports on CSEReport on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact. The Issuer is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing, and distribution company of hemp-based consumer products and solutions. The Issuer has commercialized a 99%+ pure, naturally isolated cannabinoid, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. The Issuer’s growth strategy includes the development of over-thecounter and pharmaceutical drugs and continued international expansion into Latin America, Asia, and Europe. During the month of February 2021, the Issuer actively continued general and corporate operations. FORM 7 – MONTHLY PROGRESS REPORT January 2015 Page 2 2. Provide a general overview and discussion of the activities of management. During the month of February 2021, management continued to support and control the Issuer’s business activities, develop the Issuer’s business, search for other strategic business relationships, and work towards completion and filing of its outstanding audited annual financial statements for the year ended March 31, 2020, and subsequent interim financial statements.